Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Company Update

1 Oct 2018 07:00

RNS Number : 4270C
Imaginatik PLC
01 October 2018
 

 

1 October 2018

 

Imaginatik plc

("Imaginatik" or the "Company")

 

Company Update

 

Imaginatik plc (AIM: IMTK.L) updates shareholders on the present situation.

 

Trading

 

Since the Company's announcement on 4 June 2018, the Company's financial performance has improved. This is as a result of the steps taken to reduce costs and since the start of June customers renewing their contracts, combined with new customer wins

 

The sales pipeline has been scrutinised and cleaned. Whilst this has reduced the total value, there is a significant pipeline of qualified prospects for conversion over the next two quarters, sufficient to ensure the Company can trade at budget. In addition, a new marketing programme has commenced, and this is beginning to generate an increasing number of quality leads.

 

Appointment of New Nominated Adviser

 

Further to the announcement on 26 September the Company can confirm that it is in negotiations with certain Nominated Advisers with a view to selecting a replacement as soon as possible. Shareholders will be updated as soon as a replacement Nominated Adviser has been appointed.

 

Investment

 

Several existing and new potential investors have approached the Company since the announcement on 26 September with interest and proposals. Since the management changes at the start of June, the immediate focus of the new team has been for the business to become self-funding as soon as possible and this continues to be the aim.

 

The directors would like to thank all associated with the Company in this turbulent time and want to reassure shareholders and others that the priorities of the Board are to appoint a new Nominated Adviser to ensure the shares resume trading as soon as possible and that the business performance continues to improve. Further updates will be made as appropriate.

 

For further information please contact:

 

Imaginatik plc

Via Alma

Angus Forrest CEO

Peterhouse Capital Limited - Broker

+44 (0) 20 7220 9797

Duncan Vasey / Lucy Williams

Alma PR

Tel: 020 8004 4218

Caroline Forde / Robyn Fisher

 

About Imaginatik

 

Imaginatik is the only innovation solution provider which has combined a proven innovation program with purpose-built idea management software to enable companies to achieve breakthrough and continuous innovation at scale. Imaginatik works with leading global enterprises to build and integrate innovation management skills as a core competency. Customers include ExxonMobil, Altria, Shell, Sodexo, Caterpillar, Novartis and Cargill.

 

Imaginatik is a public company traded on the AIM market of the London Stock Exchange (LSE: IMTK.L, currently suspended) with offices in Boston, MA, USA and Fareham, U.K.

 

For more information visit www.imaginatik.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPGUBUBUPRPGR
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSProposed Placing
11th Jun 20128:00 amRNSFinal Results
17th Apr 20127:00 amRNSTrading Update
17th Apr 20127:00 amRNSContract Wins
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.